Search Results
Results found for "Heptares"
Posts (45)
- California gold rush for Sosei Heptares
November 2021 "Cambridge’s Japanese-owned life sciences company Sosei Heptares has clinched a lucrative
- Verily links up with Sosei Heptares for GPCR drug discovery
Among those hitching their wagons to that star are Verily and Sosei Heptares, which have struck a research The financial details of the strategic collaboration weren’t released, but Sosei Heptares’ past two team-ups
- Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
December 2021 "Tokyo, Japan and Cambridge, UK, 24 December 2021 – Sosei Group Corporation (“Sosei Heptares the HSR Act, under the terms of the License Agreement Neurocrine Biosciences has agreed to pay Sosei Heptares
Other Pages (4)
- Dr. Chris Tate | Dr. GPCR Ecosystem
Join me to learn more about Chris’s work and his role in founding Heptares which was later acquired by Sosei and became Sosei Heptares . Chris Tate on the web LinkedIn ResearchGate Pubmed Google Scholar Sosei Heptares Wikipedia MRC Laboratory
- Chris Langmead | Dr. GPCR Ecosystem
Prior to these roles this he was Head of Pharmacology at Heptares Therapeutics Ltd., a UK-based biotechnology These successes enabled the US$400M sale of Heptares Therapeutics Ltd. to the Sosei Group Corporation Prior to joining Heptares, Chris was a neuroscience researcher at GlaxoSmithKline, UK (1998-2009).
- Dr. Fiona Marshall: Three Decades Inside GPCR Drug Discovery | Dr. GPCR Ecosystem
Chris Tate's thermostabilization strategy finally made GPCR structures routine, the insight that seeded Heptares She co-founded Heptares Therapeutics and served as Chief Scientific Officer for twelve years, through β-adrenergic signaling set a career in motion 07:07 A venture capital visit to the LMB and the founding of Heptares As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery
